Duloxetine HCL DR Capsules
This contract has been archived. It is preserved as a historical record.
Similar active opportunities:
This opportunity has closed
Similar active opportunities you might be interested in:
View all similar opportunitiesKey Takeaways
- No response deadline specified - contact the agency for details
- Full and open competition - all businesses eligible to bid
- Work to be performed in PHILADELPHIA, PA
- Industry: Pharmaceutical Preparation Manufacturing
Contract Details
- Notice ID
- SPE2D219R0052
- Opportunity Type
- Presolicitation
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEFENSE LOGISTICS AGENCY
- Office
- DLA TROOP SUPPORT
- Posted Date
- Tuesday, December 3, 2019
- Response Deadline
- Not specified
- PSC Code
- 6505
- Set-Aside
- Full & Open Competition
- Place of Performance
- PHILADELPHIA, PA, 19111
- Status
- Active
Description
Correcting Duloxetine HCL DR to reflect capsules i/l/o tablets. The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Duloxetine HCL DR. Procurement details follow.Duloxetine HCL DR Capsules 20MG-60 count bottles; 30MG-30 count bottles; 30MG-90 count bottles; 60MG-30 count bottles and 60MG-1,000 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs and Indi
Why This Opportunity Matters
The Department of DEFENSE is actively seeking qualified contractors for pharmaceutical preparation manufacturing in PHILADELPHIA, PA.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
